Connect with us

Business

Health care inflation rises as patients, employers brace for biggest jump in health spending in 15 years

Published

on

Health care inflation rises as patients, employers brace for biggest jump in health spending in 15 years


Jose Luis Pelaez Inc | Digitalvision | Getty Images

Health-care inflation is fueling higher coverage costs, setting the stage for what could be the largest increase in health-care spending by large employers in 15 years.

Medical care costs in August rose 4.2% on an annualized basis, according to the Labor Department’s Consumer Price Index, compared to an overall inflation rate of 2.9%. The cost of doctors’ visits climbed 3.5%, while hospital and outpatient services jumped 5.3%.

Those price increases are contributing to higher health insurance costs for 2026. Consumers who don’t qualify for government subsidies to buy health coverage on the Affordable Care Act exchanges could face double-digit premium increases for next year, according to early filings from insurers.

Workers with employer health coverage could also have to pay higher premium and out-of-pocket costs next year.

Large employers are projecting their overall health coverage costs will rise an average of 9% in 2026, according to several business group surveys, which would be the highest level of health-care inflation since 2010.

More than half of companies surveyed by benefits consulting firm Mercer earlier this year said they are considering passing on some of those increases to workers, but the Business Group on Health says most large employers in its survey are looking for other ways to cut costs.

“Employers have shied away in every way possible, from passing on costs to employees. This year, we see the first indication that they may look to pass some of that on to employees, but again, only as a last resort. They’re going to try and pull as many other levers as possible,” said Ellen Kelsay, BGH president and CEO.

Employer cost drivers: cancer drugs and GLP-1s

Shana Novak | Stone | Getty Images

Prescription drug prices rose 0.9% in August, according to the Consumer Price Index, which considers a range of widely-used generic and brand-name drugs.

But for large employers, expensive drugs are the major drivers of higher health spending.  

Companies surveyed by BGH are projecting a 12% increase in pharmaceutical costs next year, on top of an 11% hike this year fueled by cancer drugs and diabetes and obesity treatments like Novo Nordisk’s Wegovy and Ely Lilly’s Zepbound.

“Cancers have been for the fourth year in a row, the top condition driving healthcare costs — cancers at younger ages, later stage diagnoses,” said Kelsay, who added that pricy weight loss drugs are are a close second.

“When it comes to the treatment of obesity, that has been the space that has been the most frothy for the past two to three years and has been what has fueled a lot of this pharmaceutical spending,” she said.

Nearly two-thirds of employers with 20,000 workers or more offer access to weight loss drugs known as GLP-1s, according to Mercer. Less than half of small employers surveyed plan to offer access in 2026.  

With growing demand for the drugs, more companies are tightening eligibility requirements and beginning to explore more affordable ways to provide access for their employees, including the cash-pay market.

Cash-pay GLP-1s

A telehealth executive whose firm offers compounded GLP-1s told CNBC that some large employers are quietly letting workers know they can use health savings accounts to buy the medications for less in the cash market.

“They are worried about how much [the drugs] cost, but that doesn’t mean they don’t think their employees shouldn’t have access to them. They just don’t want to have to pay for it,” said the executive, who spoke on condition of anonymity because of the confidential nature of the discussions.

Health account data shows more workers are turning to direct-to-consumer options, including Eli Lilly’s Lilly Direct and Novo Nordisk’s Novocare online pharmacies, both of which offer their weight loss drugs at roughly half the list prices of more than $1000.

GLP-1 purchases are now the top category of cash-pay spending in pre-tax flexible spending and health savings accounts, for expenses not covered by insurance, according to the CEO of health payments processor Paytient.

“We see a tripling from last year to this year of usage at GLP-1 oriented providers. These are places like Lilly Direct, like Ro, like Hims & Hers, and that’s a growing segment,” said Paytient founder and CEO Brian Whorley.  

But employers worry that the cash-pay trend leaves lower-income workers out of the equation because they can’t afford the out-of-pocket costs. That is prompting discussions about how their companies can obtain cash-pay prices to help boost more equitable access for employees.

Self-insured employers have contracted directly with so-called Centers of Excellence for specialty medical care such as cancer treatment and joint replacements. But they can’t currently do the same for many drugs. Under agreements with pharmacy benefit management firms, or PBMs, both the drugmakers and employers would violate their contracts by using a direct cash-pay process. 

But employers are increasingly pressing PBMs for better options, says BGH’s Kelsay. They are beginning to consider new types of benefit managers, which are proposing new payment models for drugs in the development pipeline.

“There are some new entities — some startups in this space — that are building out products and solutions where they are going on behalf of a pooled group of employers to negotiate with manufacturers on certain cell and gene therapies,” she said. 

Paytient’s Whorley calls the challenge of making GLP-1s more affordable a stress test moment for employers and PBMs.

“They’re at a perfect sort of Venn Diagram of clinically effective drugs that change people’s lives, that increasingly will force a choice,” when it comes to financing, Whorley said. “If we get this right, it can provide a blueprint for all the drugs like GLP-1s that will … present challenges for health plans.”



Source link

Business

Pine Labs IPO Day 1 LIVE Updates: Issue Receives 0.13x Subscription, Retail Quota Booked Over 50%

Published

on

Pine Labs IPO Day 1 LIVE Updates: Issue Receives 0.13x Subscription, Retail Quota Booked Over 50%


Pine Labs IPO GMP Today, Price, Allotment & Listing Date: Fintech firm Pine Labs on Friday launched its initial public offering (IPO) to raise Rs 3,899.91 crore. The IPO, whose price has been fixed at Rs 210-221 apiece, will be closed on Tuesday, November 11. The company raised Rs 1,754 crore from anchor investors on Thursday, a day before the IPO.

The anchor book saw participation from 71 funds, including Franklin Templeton, Nomura, Morgan Stanley Asia Singapore Pte Ltd, Amundi Funds New Silk Road, Massachusetts Institute of Technology, BNP Paribas and Eastspring Investments, according to a circular uploaded on BSE’s website.

Pine Labs IPO GMP Today

According to market observers, unlisted shares of Pine Labs are currently trading at Rs 233 apiece in the grey market, which is a 5.43% premium (or GMP) at Rs 12 over the upper IPO price of Rs 221, indicating mild listing gains for investors.

The GMP was nearly 16% last week.

The GMP is based on market sentiments and keeps changing. ‘Grey market premium’ indicates investors’ readiness to pay more than the issue price.

Pine Labs IPO: Should You Apply?

Brokerages have given a mixed response to the Pine Labs IPO, with views split between long-term optimism and near-term caution. While some see strong potential in its business model, others find the valuation steep given its loss-making status.

Cautious Voices

Arihant Capital advised investors to avoid the issue, citing losses at the PAT level and high employee and technology costs. Swastika Investmart also suggested avoiding the IPO for now, calling it “aggressively valued” with limited short-term visibility. Angel One rated it neutral, noting that the company remains loss-making and trades at a premium to peers on an EV/EBITDA basis, while warning of risks like regulatory uncertainty and intense competition.

Long-Term Optimism

On the other hand, SBI Securities gave a ‘subscribe for long-term’ rating, citing Pine Labs’ strong network of 9.8 lakh merchants and Rs 276 trillion market opportunity by FY29. It said the firm is well placed to deliver profitable growth. IDBI Capital also recommended ‘subscribe for long-term’, highlighting Pine Labs’ Rs 11,424.97 billion transaction volume in FY25 and its strategic acquisitions that strengthen its digital infrastructure ecosystem.

Pine Labs IPO: Opening, Closing, Allotment, Listing Dates

The IPO was opened on November 7 and will be closed on November 11. Its allotment will be finalised on November 12, while the stock listing is scheduled to take place on November 14 on both BSE and NSE.



Source link

Continue Reading

Business

MPs urge Reeves to tax online betting games to reflect the harm they cause

Published

on

MPs urge Reeves to tax online betting games to reflect the harm they cause


The government has been told by MPs that it should not “cave in to industry scaremongering” about the negative effects of taxing online betting games, and that it should tax them at a rate that reflects the harm they can cause.

The recommendation from the cross-party Treasury committee comes just weeks ahead of Rachel Reeves’s Budget, in which she will be looking to plug a substantial gap in the public finances.

In its report, released on Friday, the committee warned that online betting can lead to harmful, addictive, high-frequency gambling that delivers no benefit to the people taking part, their families or their communities.

The report urged the government to “more sharply recognise that different types of gambling inflict different levels of harm”, and recommended that this be reflected in its approach to taxing the activity.

The committee’s report said that while various forms of gambling, ranging from seaside arcades and bingo through to betting on the races and football, are safely enjoyed by many people, there is “another side to the industry”.

The shift towards online betting games has picked up pace in recent years, with the proportion of the “gross gambling yield” associated with remote gaming rising from 12 per cent in 2014 to 44 per cent in 2024.

The committee had called for evidence of the possible effects of taxing the activity, as it held a series of sessions examining the choices faced by the chancellor in her forthcoming Budget. It said it rejected the industry’s assertion that gambling causes no social ills. It also heard evidence that it said both supported and challenged the gambling industry’s concern that increased taxation could drive more customers to the black market.

The committee said it recommends that the government examine how to tackle black-market gambling, and consider whether additional anti-tax-avoidance measures were needed.

The shift towards online betting games has picked up pace in recent years (Alamy/PA)

The chair of the Treasury select committee, Dame Meg Hillier, said: “Whether at a local racetrack or a seaside arcade, for many people, gambling is a fun pastime enjoyed with family and friends. But we heard that the industry is hiding its more insidious parts behind the friendly facade of its traditional, cultural forms.

“For too many people, the highly addictive and harmful nature of online betting games has seriously impacted their lives and the lives of those around them. The impacts of problem gambling in our communities are plain to see, and the industry’s boldfaced claim to our inquiry that it does no social harm is staggering.

“Online betting games are extracting huge amounts of money from people who have been funnelled into the most addictive, harmful corners of the industry via their love of sports or the occasional game of bingo. We are urging the government not to cave in to industry scaremongering, and to tax online betting games at a rate that reflects the level of harm they inflict.”

The chief executive of the Betting and Gaming Council (BGC), Grainne Hurst, said: “Further tax increases on the regulated online sector risk undermining consumer protections by pushing players towards the unsafe, unregulated black market – while reducing Treasury revenues and cutting the vital funding our members provide to British sport, including horseracing, football, rugby league, darts and snooker.

“We have always recognised that betting and gaming can lead to harm for a small minority, which is why our members are investing more than ever in safer gambling – including new stake limits on online gaming, enhanced affordability checks, swift data-driven interventions, robust advertising safeguards, and funding for a new £100m statutory levy for research, prevention, and treatment to tackle problem gambling and related harm.”

The Treasury committee has recommended that the government tax online games at a level that reflects the harm they can cause

The Treasury committee has recommended that the government tax online games at a level that reflects the harm they can cause (PA)

Ms Hurst added: “BGC members contribute £6.8bn to the economy, generate £4bn in tax, and support 109,000 jobs, while facing an effective tax rate of up to 80 percent when duties are combined with corporation tax, business rates, national insurance, VAT, and the new statutory and economic crime levies.

“Much is at stake in the chancellor’s Budget. Get it wrong, and it’s not just jobs and growth that will suffer, it’s safer gambling itself. To protect consumers and support a safer, stronger industry, we must keep gamblers playing within the regulated market.”

A spokesperson for Flutter UK and Ireland, whose brands include Paddy Power, Sky Betting & Gaming, Sportsbet and Tombola, said: “It’s not scaremongering to suggest that tax rates of 50 per cent on machine games and online games such as bingo – as demanded by the Institute for Public Policy Research – could have a significant impact on the industry, jobs and investment.

“A tax rise is not a free hit.”



Source link

Continue Reading

Business

Indian Market Recovers Early Losses Amid Buying In Banking, Fin Services Stocks

Published

on

Indian Market Recovers Early Losses Amid Buying In Banking, Fin Services Stocks


Mumbai: The domestic equity indices ended the session slightly lower on Friday, erasing early losses due to buying in banking and fin services sectors’ heavyweights in afternoon trade and support from certain positive Q2 results. 

Sensex closed at 83,216.28, down 94.73 points or 0.11 per cent. The 30-share index opened marginally lower at 83,150.15 against last session’s closing of 83,311.01. The index remained volatile during the session, hitting an intraday high and low of 83,390.11 and 82,670.95, respectively, amid a mixed approach from investors.

Nifty 50 ended the session on 25,492.30, down 17 points or 0.07 per cent.

Add Zee News as a Preferred Source


“Domestic equities rebounded from early losses as buying emerged at key support levels, though it may be premature to call this a trend reversal amid mixed earnings, cautious global cues, and persistent FII outflows,” said analysts.

Select segments found support from Q2 results, with broader indices outperforming, led by a sharp rally in financials — especially PSU banks on account of rising investor interest driven by speculation around an FDI cap hike and sector consolidation. Going forward, markets will closely monitor US shutdown and tariff-related developments with US-India and US-China deals to assess the durability of the current momentum, he added.

Bharti Airtel, Tech Mahindra, Trent, HCL Tech, Hindustan Unilever, ITC, SBI, TCS, Ultratech Cement and Tata Motors Passenger Vehicle settled in negative territory. Tata Steel, Mahindra and Mahindra, ICICI Bank, BEL, Adani Ports, Infosys and PowerGrid closed higher.

Sectoral indices remained volatile, experiencing a mixed approach from investors. Nifty FMCG fell 274 points or 0.49 per cent, and Nifty IT declined 220 points or 0.62 per cent. Meanwhile, Nifty Auto rose 153 points or 0.57 per cent, Nifty Bank increased 322 points or 0.56 per cent, and Nifty Fin Services ended the session 205 points or 0.76 per cent higher.

The broader market followed suit as well. Nifty smallcap 100 dipped 29 points or 0.16 per cent, and Nifty 100 settled flat, and Nifty midcap 100 surged 374 points or 0.63 per cent.



Source link

Continue Reading

Trending